Pharmacy Report Archives - Page 3 of 136 - Becker's Hospital Review

CPOs' rising importance: Report | FDA to trim gene therapy label | Sharp pharmacists plan strike | 1st Perjeta biosimilar OK'd | 10 systems with most 'A' hospitals

Rising CPO roles, label shifts, and labor pressures start the week in pharmacy. November 17, 2025 1. CPO role to gain importance in C-suites: Report Full story 2. Sharp HealthCare pharmacists to strike in California Full story 3. Beth Israel…

10 key trends for pharmacy leaders | FDA debuts pathway for personalized drugs | Amazon Pharmacy expands same-day delivery | Where are Leapfrog's straight-'A', 'F' hospitals?

From personalized drugs to faster delivery — pharmacy’s next era takes shape. November 13, 2025 1. 10 key trends for pharmacy executives: Becker's Fall CPO Summit Full story 2. FDA opens new approval route for personalized treatments Full story 3.…

Eli Lilly drops CVS Caremark | Ky. system plans central fill pharmacy | 10 systems seeking pharmacy leaders | FDA's new drug evaluation chief | Trump floats sending ACA funds to consumers

Eli Lilly drops CVS Caremark, systems seeking pharma leaders & Norton’s new central fill pharmacy November 12, 2025 1. Eli Lilly to drop CVS drug benefits plan for employees Full story 2. GLP-1s linked to 'dramatically' lower mortality among colon…

FDA removes hormone therapy warnings | GI drug recalled | Providence's 340B rebate plan | Mark Cuban pharmacy adds Stelara biosimilar | Va. system grows free Rx delivery

From FDA label changes to 340B pilots — pharmacy leaders adjust course. November 11, 2025 1. FDA to remove boxed warnings from hormone therapy for menopause Full story 2. Fresenius Kabi recalls 3 lots of GI drug Full story 3.…

Trump's drug pricing deals, explained | Medicaid Rx cost pilot: 8 details | Calif. system averts strike with pharmacists | Patient dies in gene therapy study | Pfizer wins Metsera bidding war

Pricing reforms and Medicaid pilots lead this week. November 10, 2025 1. CMS launches pilot to lower Medicaid drug costs: 8 things to know Full story 2. Trump administration's drug pricing deals, explained Full story 3. Pharmacy labor costs down…

Medicare to cover GLP-1s | Court OKs 340B contract pharmacies in Colo. | 10 systems seeking pharmacy leaders | Pfizer-Novo bidding war heats up: 5 notes | 3 drug, device recalls

Key 340B, pricing, recall updates for pharmacy leaders November 6, 2025 1. Medicare to cover GLP-1s under Trump-negotiated pricing Full story 2. Court rejects AbbVie's push to restrict 340B protections Full story 3. Hartford HealthCare is cutting nurse strain + improving…

Amid 14 new drug shortages, hospitals strive for fixes | Ballad unites Rx dispensing, IV compounding | Pharmacies fill data gaps | 81 systems with strong finances

From shortages to system strength — hospitals push for pharmacy stability. November 5, 2025 1. 14 drugs in shortage Full story 2. Hospitals strive for long-term fix to drug shortages Full story 3. Nebraska Medicine shares GenAI RCM wins live…

Pharmacy execs share 5-year plans | Pfizer sues Novo Nordisk, Metsera | 3 GLP-1 updates | The state of chemotherapy drug shortages | 20 best places to retire: US News

From long-term plans to supply strain — pharmacy’s challenges come into focus. November 4, 2025 1. How C-suite pharmacy leaders plan to thrive in the near future Full story 2. Pfizer sues Metsera, Novo Nordisk over failed merger Full story…

FDA's top drug regulator exits amid probe | 340B rebate pilot gains steam | 22 cancer drugs in shortage: 7 notes | 3 Joint Commission moves | Kleenex co. to buy Tylenol maker for $48.7B

From FDA shake-ups to 340B pilots — pharmacy leaders brace for change. November 3, 2025 1. FDA's top drug regulator resigns amid investigation Full story 2. HRSA to launch 340B rebate pilot with 8 drugmakers: 5 notes Full story 3.…

Pfizer, Novo Nordisk spar over NY drugmaker | Novant's pharmacy bet pays off | 10 systems seeking pharmacy leaders | Carcinogen spurs Teva drug recall | CVS reports $4B Q3 loss

From pharma rivalries to recalls — pressure mounts across the industry. October 30, 2025 1. Pfizer says Novo Nordisk's Metsera bid breaks law Full story 2. How Novant's bet on pharmacy is improving patient outcomes Full story 3. As essential…